Activity Overview
Welcome to this OncoByte Adaptive Learning Pathway!
Each OncoByte video consists of a 5-minute presentation delivered by our expert faculty on a key foundational topic regarding the management of chronic graft-vs-host disease (GVHD).
Prior to watching an OncoByte, you will be asked a question on the topic to assess your baseline knowledge and confidence. If you answer the question correctly and confidently, you will continue to the next topic. If you answer the question incorrectly or without high confidence, you will continue to the OncoByte video.
After proceeding through your customized learning pathway, you will be led to a panel discussion where our expert faculty will help you synthesize the latest information and data on chronic GVHD and incorporate best practices for routine management.
Target Audience
This educational activity is directed toward physicians, hematologists, nurses, nurse practitioners, physician assistants, pharmacists, and other health care providers involved in the diagnosis and treatment of GVHD.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the mechanism of action for current and emerging therapies being evaluated for the prophylaxis and treatment of GVHD
- Analyze efficacy and safety from recent and ongoing clinical trials evaluating targeted therapies for the treatment of GVHD
- Integrate current evidence and treatment guidelines to personalize care for GVHD
- Utilize strategies to readily identify and optimally manage treatment-related toxicities in patients with GVHD
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here